Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Responsiveness to Treatment of the Experience Sampling Method (ESM) in Irritable Bowel Syndrome (IBS) Using Linaclotide

NCT03336034 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03336034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Responsiveness to Treatment of the Experience Sampling Method (ESM) in Irritable Bowel Syndrome (IBS) Using Linaclotide
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Terminated
Start date
January 1, 2018
Completion date
May 1, 2022
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation-predominant irritable bowel syndrome